Home › Trials › NCT05978466
Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry for managing outcomes in patients with atrial fibrillation

Official title: MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)

Run by CorVita Science Foundation · NCT05978466 · Data updated 2026-11-12

This study is creating a registry to track how patients with atrial fibrillation are treated and their outcomes, aiming to improve care and reduce the risk of complications like strokes.

More Atrial Fibrillation trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorCorVita Science Foundation
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedDecember 22, 2017
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJanuary 18, 2024
Trial IDNCT05978466 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults diagnosed with either valvular or non-valvular atrial fibrillation.

Probably not a fit

Patients under 18 years old or those with a clinical prognosis of death within six months may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to gather data on the management of patients diagnosed with atrial fibrillation (AF), a condition characterized by irregular heartbeats that increase the risk of stroke. The study will create a registry to track treatment patterns and outcomes, including the prevention of thrombo-embolic events and the effectiveness of various interventions. By documenting the natural history of AF and associated complications, the registry will help identify trends in patient care across different demographics and treatment approaches. The goal is to improve understanding and management of AF to enhance patient outcomes.

Why it matters

Potential benefit: If successful, this registry could lead to improved management strategies for patients with atrial fibrillation, potentially reducing the risk of stroke and other complications.

How similar studies have gone: Other studies have successfully utilized registries to improve understanding and management of atrial fibrillation, indicating that this approach has potential for meaningful insights.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

1. Diagnosis of valvular or non valvular atrial fibrillation
2. ECG documented atrial fibrillation A. 12 lead B. Rhythm strip C. Event monitor D. Holter Monitor E. Implantable loop recorder

Exclusion Criteria:

1. Age below 18 years.
2. Clinical evidence that death within 6 months is possible
3. Inability to consent to the research or sign a consent form
4. Inability to follow up at the research clinic at least annually for continuity of AF care and management

Where it's running

  • CorVita Science Foundation (NFP)
    Chicago, Illinois, United States     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Atrial Fibrillation 390CorVita Science Foundation 2
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.